Dordaviprone dihydrochlorideProduct ingredient for Dordaviprone

Name
Dordaviprone dihydrochloride
Drug Entry
Dordaviprone

Dordaviprone (ONC-201) is under investigation in clinical trial NCT03394027 (ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma).

Accession Number
DBSALT003291
Structure
Synonyms
7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one-2HCl
UNII
53VG71J90J
CAS Number
1638178-82-1
Not Available
Predicted Properties
Not Available